Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression L Casadei, F Calore, CJ Creighton, M Guescini, K Batte, OH Iwenofu, ... Cancer research 77 (14), 3846-3856, 2017 | 171 | 2017 |
SAR405838: a novel and potent inhibitor of the MDM2: p53 axis for the treatment of dedifferentiated liposarcoma KLJ Bill, J Garnett, I Meaux, XY Ma, CJ Creighton, S Bolshakov, ... Clinical cancer research 22 (5), 1150-1160, 2016 | 102 | 2016 |
Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors H Shang, D Braggio, YJ Lee, GA Al Sannaa, CJ Creighton, S Bolshakov, ... Cancer 121 (22), 4088-4096, 2015 | 81 | 2015 |
HDAC8, a potential therapeutic target for the treatment of malignant peripheral nerve sheath tumors (MPNST) G Lopez, KLJ Bill, HK Bid, D Braggio, D Constantino, B Prudner, A Zewdu, ... PLoS One 10 (7), e0133302, 2015 | 55 | 2015 |
MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes L Casadei, F Calore, DA Braggio, A Zewdu, AA Deshmukh, P Fadda, ... Cancer research 79 (19), 4911-4922, 2019 | 31 | 2019 |
Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors E Braggio, DDA Braggio, IA Small, LF Lopes, M Valadão, ME Gouveia, ... Anticancer research 30 (6), 2407-2414, 2010 | 30 | 2010 |
Cross‐flow microfiltration for isolation, selective capture and release of liposarcoma extracellular vesicles L Casadei, A Choudhury, P Sarchet, P Mohana Sundaram, G Lopez, ... Journal of extracellular vesicles 10 (4), e12062, 2021 | 25 | 2021 |
Autophagy inhibition overcomes sorafenib resistance in S45F‐mutated desmoid tumors D Braggio, D Koller, F Jin, N Siva, A Zewdu, G Lopez, K Batte, L Casadei, ... Cancer 125 (15), 2693-2703, 2019 | 23 | 2019 |
β-catenin S45F mutation results in apoptotic resistance D Braggio, A Zewdu, P Londhe, P Yu, G Lopez, K Batte, D Koller, ... Oncogene 39 (34), 5589-5600, 2020 | 20 | 2020 |
Verticillin A inhibits leiomyosarcoma and malignant peripheral nerve sheath tumor growth via induction of apoptosis A Zewdu, G Lopez, D Braggio, C Kenny, D Constantino, HK Bid, K Batte, ... Clinical & experimental pharmacology 6 (6), 2016 | 16 | 2016 |
Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients M Valadão, D Braggio, AF Santos, HK Pimenta-Inada, E Linhares, ... journal of surgical research 178 (1), 288-293, 2012 | 15 | 2012 |
miR-133a function in the pathogenesis of dedifferentiated liposarcoma PY Yu, G Lopez, D Braggio, D Koller, KLJ Bill, BC Prudner, A Zewdu, ... Cancer cell international 18, 1-10, 2018 | 13 | 2018 |
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates G Lopez, D Braggio, A Zewdu, L Casadei, K Batte, HK Bid, D Koller, P Yu, ... PLoS One 12 (11), e0188859, 2017 | 12 | 2017 |
TGF-β and CTGF are mitogenic output mediators of Wnt/β-catenin signaling in desmoid fibromatosis S Varghese, DA Braggio, J Gillespie, AE Toland, R Pollock, J Mayerson, ... Applied Immunohistochemistry & Molecular Morphology 25 (8), 559-565, 2017 | 11 | 2017 |
Adipose tumor microenvironment A Zewdu, L Casadei, RE Pollock, D Braggio Tumor Microenvironments in Organs: From the Brain to the Skin–Part A, 73-86, 2020 | 10 | 2020 |
Multi-layer micro-nanofluidic device for isolation and capture of extracellular vesicles derived from liposarcoma cell conditioned media PM Sundaram, L Casadei, G Lopez, D Braggio, G Balakirsky, R Pollock, ... Journal of Microelectromechanical Systems 29 (5), 776-782, 2020 | 9 | 2020 |
Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors DA Braggio, F Costas C. de Faria, D Koller, F Jin, A Zewdu, G Lopez, ... Plos one 17 (10), e0276047, 2022 | 6 | 2022 |
A retrospective collection of diagnostic data from the desmoid tumor research foundation natural history study. A Lucas, D Braggio, L Hernandez, K Mercier Journal of Clinical Oncology 39 (15_suppl), e23549-e23549, 2021 | 3 | 2021 |
The profile of platelet-derived growth factor receptor alpha (PDGFRA) gene alterations in GIST patients (pts) from Brazil DA Braggio, E Braggio, IA Small, CE Bacchi, LF Lopes, M Valadao, ... Journal of Clinical Oncology 26 (15_suppl), 10561-10561, 2008 | 3 | 2008 |
Protein kinase C θ (PKCθ) expression as a potential diagnostic marker for KIT-negative GIST DA Braggio, S Romano, IA Small, FA Soares, CG Ferreira, DP Guimarães Journal of Clinical Oncology 27 (15_suppl), 10561-10561, 2009 | 1 | 2009 |